Found: 13
Select item for more details and to access through your institution.
Prevalence of Pretreatment Testing Recommended for Patients With Chronic Inflammatory Skin Diseases.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 3, p. 334, doi. 10.1001/jamadermatol.2023.5895
- By:
- Publication type:
- Article
Venous Thromboembolism in Patients With Bullous Pemphigoid.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 7, p. 750, doi. 10.1001/jamadermatol.2023.1461
- By:
- Publication type:
- Article
Risk of Infection in Children With Psoriasis Receiving Treatment With Ustekinumab, Etanercept, or Methotrexate Before and After Labeling Expansion.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 3, p. 289, doi. 10.1001/jamadermatol.2022.6325
- By:
- Publication type:
- Article
Venous Thromboembolism in Chronic Inflammatory Skin Diseases-The Need to Consider Bullous Pemphigoid-Reply.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Risk of Inflammatory Arthritis After a New Diagnosis of Hidradenitis Suppurativa.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Rationale and Design of the Brigham Cohort for psoriasis and psoriatic arthritis registry (COPPAR).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Round Table - new concept of the Arbeitsgemeinschaft Dermatologische Forschung to foster regional exchange between young clinician scientists in dermatology.
- Published in:
- Experimental Dermatology, 2016, v. 25, n. 10, p. 827, doi. 10.1111/exd.13052
- By:
- Publication type:
- Article
Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study.
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 5, p. 692, doi. 10.1111/bjd.21704
- By:
- Publication type:
- Article
Validation of alopecia coding in US claims data among women of childbearing age.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 4, p. 1, doi. 10.1002/pds.5782
- By:
- Publication type:
- Article
Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 5, p. 567, doi. 10.1002/pds.5586
- By:
- Publication type:
- Article
Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 2, p. 167, doi. 10.1002/pds.5356
- By:
- Publication type:
- Article
Longitudinal utilization of systemic immunomodulators before and after dupilumab approval in children with atopic dermatitis.
- Published in:
- Pediatric Dermatology, 2023, v. 40, n. 1, p. 132, doi. 10.1111/pde.15172
- By:
- Publication type:
- Article